Stempoint Capital’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$403K Sell
248,972
-1
-0% -$3 0.07% 78
2026
Q2
$1.2M Buy
+248,973
New +$883K 0.21% 69

Other funds holding CALC

Stempoint Capital's CALC Position: Q3 2026 in Review

Stempoint Capital reduced its CalciMedica (CALC) stake by 0% in Q3 2026, selling an estimated $3 and leaving 248,972 shares worth $403K. The position accounts for 0.07% of the portfolio, ranked #78.

Stempoint Capital first reported a position in CALC in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.2M in Q2 2026. 17 funds tracked by Wall St. Rank hold CALC as of Q3 2026.

  • Stempoint Capital held 248,972 shares of CalciMedica worth $403K as of Q3 2026.
  • Stempoint Capital sold 1 CalciMedica share in Q3 2026, an estimated $3.
  • CalciMedica made up 0.07% of Stempoint Capital's portfolio in Q3 2026, its #78 holding.
  • Stempoint Capital first reported a position in CalciMedica in Q2 2026 and has held it in 2 quarters since.
  • Stempoint Capital's CalciMedica position peaked at $1.2M in Q2 2026.
  • 17 funds tracked by Wall St. Rank held CalciMedica as of Q3 2026.

Based on Stempoint Capital's 13F filing for Q3 2026, filed 16 Nov 2026.